Molecular biology of epilepsy genes

Experimental Neurology

Volumn 244, Issue , 2013, Pages 51-58

  Williams, Charles A ^a   Battaglia, Agatino ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

Author keywords

15q12; 15q13.3; 16p11.3; ARX; Chromosomes; Epilepsy; Genetics; GWAS; Multifactorial; SCN1A

Indexed keywords

ANTICONVULSIVE AGENT; SODIUM CHANNEL NAV1.1;

ARX GENE; CHROMOSOME DISORDER; COHORT ANALYSIS; COPY NUMBER VARIATION; DISEASE ACTIVITY; DISEASE COURSE; ENVIRONMENTAL FACTOR; EPILEPSY; EPILEPSY GENE; EPILEPTIC STATE; EPILEPTOGENESIS; GABAERGIC SYSTEM; GENE; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENETIC DISORDER; GENETIC RISK; HERITABILITY; HETEROZYGOTE; HUMAN; HUMAN GENOME; INHERITANCE; INTERNEURON; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MULTIFACTORIAL INHERITANCE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SCN1A GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EPILEPSY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR BIOLOGY; MULTIFACTORIAL INHERITANCE; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; TRANSCRIPTION FACTORS;

EID: 84877592699     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.12.001     Document Type: Review

References (85)

1. Anderson V.E., Rich S.S., Hauser W.A., Wilcox K.J. Family studies of epilepsy. Epilepsy Res. Suppl. 1991, 4:89-103.
2. Archer H.L., Whatley S.D., Evans J.C., Ravine D., Huppke P., Kerr A., Bunyan D., Kerr B., Sweeney E., Davies S.J., Reardon W., Horn J., MacDermot K.D., Smith R.A., Magee A., Donaldson A., Crow Y., Hermon G., Miedzybrodzka Z., Cooper D.N., Lazarou L., Butler R., Sampson J., Pilz D.T., Laccone F., Clarke A.J. Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients. J. Med. Genet. 2006, 43(5):451-456.
3. Bahi-Buisson N., Guellec I., Nabbout R., Guet A., Nguyen G., Dulac O., Chiron C. Parental view of epilepsy in Rett syndrome. Brain Dev. 2008, 30(2):126-130.
4. Bahi-Buisson N., Guttierrez-Delicado E., Soufflet C., Rio M., Daire V.C., Lacombe D., Heron D., Verloes A., Zuberi S., Burglen L., Afenjar A., Moutard M.L., Edery P., Novelli A., Bernardini L., Dulac O., Nabbout R., Plouin P., Battaglia A. Spectrum of epilepsy in terminal 1p36 deletion syndrome. Epilepsia 2008, 49(3):509-515.
5. Bahi-Buisson N., Nectoux J., Rosas-Vargas H., Milh M., Boddaert N., Girard B., Cances C., Ville D., Afenjar A., Rio M., Heron D., N'Guyen Morel M.A., Arzimanoglou A., Philippe C., Jonveaux P., Chelly J., Bienvenu T. Key clinical features to identify girls with CDKL5 mutations. Brain 2008, 131(Pt 10):2647-2661.
6. Battaglia A. The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J. Rare Dis. 2008, 3:30.
7. Battaglia A., Guerrini R. Chromosomal disorders associated with epilepsy. Epileptic Disord. 2005, 7(3):181-192.
8. Battaglia A., Filippi T., South S.T., Carey J.C. Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome: experience with 87 patients. Dev. Med. Child Neurol. 2009, 51(5):373-380.
9. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., Engel J., French J., Glauser T.A., Mathern G.W., Moshe S.L., Nordli D., Plouin P., Scheffer I.E. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
10. Berkovic S.F., Howell R.A., Hay D.A., Hopper J.L. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann. Neurol. 1998, 43(4):435-445.
11. Bonati M.T., Combi R., Asselta R., Duga S., Malcovati M., Oldani A., Zucconi M., Ferini-Strambi L., Dalpra L., Tenchini M.L. Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families. J. Neurol. 2002, 249(8):967-974.
12. Bremer A., Giacobini M., Eriksson M., Gustavsson P., Nordin V., Fernell E., Gillberg C., Nordgren A., Uppstromer A., Anderlid B.M., Nordenskjold M., Schoumans J. Copy number variation characteristics in subpopulations of patients with autism spectrum disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011, 156(2):115-124.
13. Catterall W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000, 26(1):13-25.
14. Cichon S., Craddock N., Daly M., Faraone S.V., Gejman P.V., Kelsoe J., Lehner T., Levinson D.F., Moran A., Sklar P., Sullivan P.F. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am. J. Psychiatry 2009, 166(5):540-556.
15. Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 2001, 68(6):1327-1332.
16. Colasante G., Collombat P., Raimondi V., Bonanomi D., Ferrai C., Maira M., Yoshikawa K., Mansouri A., Valtorta F., Rubenstein J.L., Broccoli V. Arx is a direct target of Dlx2 and thereby contributes to the tangential migration of GABAergic interneurons. J. Neurosci. 2008, 28(42):10674-10686.
17. Colombo E., Collombat P., Colasante G., Bianchi M., Long J., Mansouri A., Rubenstein J.L., Broccoli V. Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation. J. Neurosci. 2007, 27(17):4786-4798.
18. De Jonghe P. Molecular genetics of Dravet syndrome. Dev. Med. Child Neurol. 2011, 53(Suppl. 2):7-10.
19. de Kovel C.G., Trucks H., Helbig I., Mefford H.C., Baker C., Leu C., Kluck C., Muhle H., von Spiczak S., Ostertag P., Obermeier T., Kleefuss-Lie A.A., Hallmann K., Steffens M., Gaus V., Klein K.M., Hamer H.M., Rosenow F., Brilstra E.H., Trenite D.K., Swinkels M.E., Weber Y.G., Unterberger I., Zimprich F., Urak L., Feucht M., Fuchs K., Moller R.S., Hjalgrim H., De Jonghe P., Suls A., Ruckert I.M., Wichmann H.E., Franke A., Schreiber S., Nurnberg P., Elger C.E., Lerche H., Stephani U., Koeleman B.P., Lindhout D., Eichler E.E., Sander T. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010, 133(Pt 1):23-32.
20. Depienne C., Trouillard O., Gourfinkel-An I., Saint-Martin C., Bouteiller D., Graber D., Barthez-Carpentier M.A., Gautier A., Villeneuve N., Dravet C., Livet M.O., Rivier-Ringenbach C., Adam C., Dupont S., Baulac S., Heron D., Nabbout R., Leguern E. Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J. Med. Genet. 2010, 47(6):404-410.
21. Depienne C., Trouillard O., Bouteiller D., Gourfinkel-An I., Poirier K., Rivier F., Berquin P., Nabbout R., Chaigne D., Steschenko D., Gautier A., Hoffman-Zacharska D., Lannuzel A., Lackmy-Port-Lis M., Maurey H., Dusser A., Bru M., Gilbert-Dussardier B., Roubertie A., Kaminska A., Whalen S., Mignot C., Baulac S., Lesca G., Arzimanoglou A., LeGuern E. Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females. Hum. Mutat. 2011, 32(1):E1959-E1975.
22. Dibbens L.M., Tarpey P.S., Hynes K., Bayly M.A., Scheffer I.E., Smith R., Bomar J., Sutton E., Vandeleur L., Shoubridge C., Edkins S., Turner S.J., Stevens C., O'Meara S., Tofts C., Barthorpe S., Buck G., Cole J., Halliday K., Jones D., Lee R., Madison M., Mironenko T., Varian J., West S., Widaa S., Wray P., Teague J., Dicks E., Butler A., Menzies A., Jenkinson A., Shepherd R., Gusella J.F., Afawi Z., Mazarib A., Neufeld M.Y., Kivity S., Lev D., Lerman-Sagie T., Korczyn A.D., Derry C.P., Sutherland G.R., Friend K., Shaw M., Corbett M., Kim H.G., Geschwind D.H., Thomas P., Haan E., Ryan S., McKee S., Berkovic S.F., Futreal P.A., Stratton M.R., Mulley J.C., Gecz J. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat. Genet. 2008, 40(6):776-781.
23. Dibbens L.M., Mullen S., Helbig I., Mefford H.C., Bayly M.A., Bellows S., Leu C., Trucks H., Obermeier T., Wittig M., Franke A., Caglayan H., Yapici Z., Sander T., Eichler E.E., Scheffer I.E., Mulley J.C., Berkovic S.F. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum. Mol. Genet. 2009, 18(19):3626-3631.
24. Dravet C. Les epilepsies graves de l'enfant. Vie Med. 1978, 8:543-548.
25. Dravet C. The core Dravet syndrome phenotype. Epilepsia 2011, 52(Suppl. 2):3-9.
26. Elia M., Striano P., Fichera M., Gaggero R., Castiglia L., Galesi O., Malacarne M., Pierluigi M., Amato C., Musumeci S.A., Romano C., Majore S., Grammatico P., Zara F., Striano S., Faravelli F. 6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases. Epilepsia 2006, 47(5):830-838.
27. Endris V., Hackmann K., Neuhann T.M., Grasshoff U., Bonin M., Haug U., Hahn G., Schallner J.C., Schrock E., Tinschert S., Rappold G., Moog U. Homozygous loss of CHRNA7 on chromosome 15q13.3 causes severe encephalopathy with seizures and hypotonia. Am. J. Med. Genet. A 2010, 152A(11):2908-2911.
28. EpiGAD EGAD. 2010.
29. Escayg A., Goldin A.L. Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia 2010, 51(9):1650-1658.
30. Escayg A., MacDonald B.T., Meisler M.H., Baulac S., Huberfeld G., An-Gourfinkel I., Brice A., LeGuern E., Moulard B., Chaigne D., Buresi C., Malafosse A. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet. 2000, 24(4):343-345.
31. Friocourt G., Kanatani S., Tabata H., Yozu M., Takahashi T., Antypa M., Raguenes O., Chelly J., Ferec C., Nakajima K., Parnavelas J.G. Cell-autonomous roles of ARX in cell proliferation and neuronal migration during corticogenesis. J. Neurosci. 2008, 28(22):5794-5805.
32. Fulp C.T., Cho G., Marsh E.D., Nasrallah I.M., Labosky P.A., Golden J.A. Identification of Arx transcriptional targets in the developing basal forebrain. Hum. Mol. Genet. 2008, 17(23):3740-3760.
33. Giordano L., Sartori S., Russo S., Accorsi P., Galli J., Tiberti A., Bettella E., Marchi M., Vignoli A., Darra F., Murgia A., Bernardina B.D. Familial Ohtahara syndrome due to a novel ARX gene mutation. Am. J. Med. Genet. A 2010, 152A(12):3133-3137.
34. Hauser W.A., Annegers J.F., Rocca W.A. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin. Proc. 1996, 71(6):576-586.
35. Heinzen E.L., Radtke R.A., Urban T.J., Cavalleri G.L., Depondt C., Need A.C., Walley N.M., Nicoletti P., Ge D., Catarino C.B., Duncan J.S., Kasperaviciute D., Tate S.K., Caboclo L.O., Sander J.W., Clayton L., Linney K.N., Shianna K.V., Gumbs C.E., Smith J., Cronin K.D., Maia J.M., Doherty C.P., Pandolfo M., Leppert D., Middleton L.T., Gibson R.A., Johnson M.R., Matthews P.M., Hosford D., Kalviainen R., Eriksson K., Kantanen A.M., Dorn T., Hansen J., Kramer G., Steinhoff B.J., Wieser H.G., Zumsteg D., Ortega M., Wood N.W., Huxley-Jones J., Mikati M., Gallentine W.B., Husain A.M., Buckley P.G., Stallings R.L., Podgoreanu M.V., Delanty N., Sisodiya S.M., Goldstein D.B. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am. J. Hum. Genet. 2010, 86(5):707-718.
36. Hemminki K., Li X., Johansson S.E., Sundquist K., Sundquist J. Familial risks for epilepsy among siblings based on hospitalizations in Sweden. Neuroepidemiology 2006, 27(2):67-73.
37. Hopkin R.J., Schorry E., Bofinger M., Milatovich A., Stern H.J., Jayne C., Saal H.M. New insights into the phenotypes of 6q deletions. Am. J. Med. Genet. 1997, 70(4):377-386.
38. Im H.I., Hollander J.A., Bali P., Kenny P.J. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 2010, 13(9):1120-1127.
39. Jia P., Ewers J.M., Zhao Z. Prioritization of epilepsy associated candidate genes by convergent analysis. PLoS One 2011, 6(2):e17162.
40. Kasperaviciute D., Catarino C.B., Heinzen E.L., Depondt C., Cavalleri G.L., Caboclo L.O., Tate S.K., Jamnadas-Khoda J., Chinthapalli K., Clayton L.M., Shianna K.V., Radtke R.A., Mikati M.A., Gallentine W.B., Husain A.M., Alhusaini S., Leppert D., Middleton L.T., Gibson R.A., Johnson M.R., Matthews P.M., Hosford D., Heuser K., Amos L., Ortega M., Zumsteg D., Wieser H.G., Steinhoff B.J., Kramer G., Hansen J., Dorn T., Kantanen A.M., Gjerstad L., Peuralinna T., Hernandez D.G., Eriksson K.J., Kalviainen R.K., Doherty C.P., Wood N.W., Pandolfo M., Duncan J.S., Sander J.W., Delanty N., Goldstein D.B., Sisodiya S.M. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain 2010, 133(Pt 7):2136-2147.
41. Kato M., Dobyns W.B. X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, "interneuronopathy". J. Child Neurol. 2005, 20(4):392-397.
42. Kato M., Das S., Petras K., Sawaishi Y., Dobyns W.B. Polyalanine expansion of ARX associated with cryptogenic West syndrome. Neurology 2003, 61(2):267-276.
43. Kato M., Das S., Petras K., Kitamura K., Morohashi K., Abuelo D.N., Barr M., Bonneau D., Brady A.F., Carpenter N.J., Cipero K.L., Frisone F., Fukuda T., Guerrini R., Iida E., Itoh M., Lewanda A.F., Nanba Y., Oka A., Proud V.K., Saugier-Veber P., Schelley S.L., Selicorni A., Shaner R., Silengo M., Stewart F., Sugiyama N., Toyama J., Toutain A., Vargas A.L., Yanazawa M., Zackai E.H., Dobyns W.B. Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum. Mutat. 2004, 23(2):147-159.
44. Kato M., Koyama N., Ohta M., Miura K., Hayasaka K. Frameshift mutations of the ARX gene in familial Ohtahara syndrome. Epilepsia 2010, 51(9):1679-1684.
45. Kitamura K., Itou Y., Yanazawa M., Ohsawa M., Suzuki-Migishima R., Umeki Y., Hohjoh H., Yanagawa Y., Shinba T., Itoh M., Nakamura K., Goto Y. Three human ARX mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice. Hum. Mol. Genet. 2009, 18(19):3708-3724.
46. Kjeldsen M.J., Kyvik K.O., Christensen K., Friis M.L. Genetic and environmental factors in epilepsy: a population-based study of 11900 Danish twin pairs. Epilepsy Res. 2001, 44(2-3):167-178.
47. Levinson D.F., Duan J., Oh S., Wang K., Sanders A.R., Shi J., Zhang N., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Kendler K.S., Freedman R., Dudbridge F., Pe'er I., Hakonarson H., Bergen S.E., Fanous A.H., Holmans P.A., Gejman P.V. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am. J. Psychiatry 2011, 168(3):302-316.
48. Lobo I. Multifactorial inheritance and genetic disease. Nat. Educ. 2008, 1(1).
49. Mabb A.M., Judson M.C., Zylka M.J., Philpot B.D. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 2011, 34:293-303.
50. Marini C., Mei D., Temudo T., Ferrari A.R., Buti D., Dravet C., Dias A.I., Moreira A., Calado E., Seri S., Neville B., Narbona J., Reid E., Michelucci R., Sicca F., Cross H.J., Guerrini R. Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia 2007, 48(9):1678-1685.
51. Marini C., Scheffer I.E., Nabbout R., Mei D., Cox K., Dibbens L.M., McMahon J.M., Iona X., Carpintero R.S., Elia M., Cilio M.R., Specchio N., Giordano L., Striano P., Gennaro E., Cross J.H., Kivity S., Neufeld M.Y., Afawi Z., Andermann E., Keene D., Dulac O., Zara F., Berkovic S.F., Guerrini R., Mulley J.C. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia 2009, 50(7):1670-1678.
52. Marini C., Scheffer I.E., Nabbout R., Suls A., De Jonghe P., Zara F., Guerrini R. The genetics of Dravet syndrome. Epilepsia 2011, 52(Suppl. 2):24-29.
53. Marsh E., Fulp C., Gomez E., Nasrallah I., Minarcik J., Sudi J., Christian S.L., Mancini G., Labosky P., Dobyns W., Brooks-Kayal A., Golden J.A. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 2009, 132(Pt 6):1563-1576.
54. Masurel-Paulet A., Andrieux J., Callier P., Cuisset J.M., Le Caignec C., Holder M., Thauvin-Robinet C., Doray B., Flori E., Alex-Cordier M.P., Beri M., Boute O., Delobel B., Dieux A., Vallee L., Jaillard S., Odent S., Isidor B., Beneteau C., Vigneron J., Bilan F., Gilbert-Dussardier B., Dubourg C., Labalme A., Bidon C., Gautier A., Pernes P., Pinoit J.M., Huet F., Mugneret F., Aral B., Jonveaux P., Sanlaville D., Faivre L. Delineation of 15q13.3 microdeletions. Clin. Genet. 2010, 78(2):149-161.
55. Mefford H.C., Muhle H., Ostertag P., von Spiczak S., Buysse K., Baker C., Franke A., Malafosse A., Genton P., Thomas P., Gurnett C.A., Schreiber S., Bassuk A.G., Guipponi M., Stephani U., Helbig I., Eichler E.E. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet. 2010, 6(5):e1000962.
56. Meisler M.H., O'Brien J.E., Sharkey L.M. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J. Physiol. 2010, 588(Pt 11):1841-1848.
57. Mulley J.C., Scheffer I.E., Petrou S., Dibbens L.M., Berkovic S.F., Harkin L.A. SCN1A mutations and epilepsy. Hum. Mutat. 2005, 25(6):535-542.
58. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., Takeuchi T., Itohara S., Yanagawa Y., Obata K., Furuichi T., Hensch T.K., Yamakawa K. Na(v)1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 2007, 27(22):5903-5914.
59. Online Mendelian Inheritance in Man McKusick-Nathans Institute of Genetic Medicine 2011, Johns Hopkins University, Baltimore, MD.
60. Pintaudi M., Calevo M.G., Vignoli A., Parodi E., Aiello F., Baglietto M.G., Hayek Y., Buoni S., Renieri A., Russo S., Cogliati F., Giordano L., Canevini M., Veneselli E. Epilepsy in Rett syndrome: clinical and genetic features. Epilepsy Behav. 2010, 19(3):296-300.
61. Poduri A., Lowenstein D. Epilepsy genetics-past, present, and future. Curr. Opin. Genet. Dev. 2011, 21:325-332.
62. Price M.G., Yoo J.W., Burgess D.L., Deng F., Hrachovy R.A., Frost J.D., Noebels J.L. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J. Neurosci. 2009, 29(27):8752-8763.
63. Rosenfeld J.A., Ballif B.C., Torchia B.S., Sahoo T., Ravnan J.B., Schultz R., Lamb A., Bejjani B.A., Shaffer L.G. Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. Genet. Med. 2010, 12(11):694-702.
64. Saitsu H., Kato M., Mizuguchi T., Hamada K., Osaka H., Tohyama J., Uruno K., Kumada S., Nishiyama K., Nishimura A., Okada I., Yoshimura Y., Hirai S., Kumada T., Hayasaka K., Fukuda A., Ogata K., Matsumoto N. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat. Genet. 2008, 40(6):782-788.
65. Schaller K.L., Krzemien D.M., McKenna N.M., Caldwell J.H. Alternatively spliced sodium channel transcripts in brain and muscle. J. Neurosci. 1992, 12(4):1370-1381.
66. Scheffer I.E. Does genotype determine phenotype? Sodium channel mutations in Dravet syndrome and GEFS+. Neurology 2011, 76(7):588-589.
67. Scheffer I.E., Zhang Y.H., Jansen F.E., Dibbens L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?. Brain Dev. 2009, 31(5):394-400.
68. Shaw C.J., Lupski J.R. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum. Mol. Genet. 2004, 13. Spec No 1:R57-64.
69. Shoubridge C., Fullston T., Gecz J. ARX spectrum disorders: making inroads into the molecular pathology. Hum. Mutat. 2010, 31(8):889-900.
70. Singh N.A., Pappas C., Dahle E.J., Claes L.R., Pruess T.H., De Jonghe P., Thompson J., Dixon M., Gurnett C., Peiffer A., White H.S., Filloux F., Leppert M.F. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet. 2009, 5(9):e1000649.
71. Sisodiya S.M., Mefford H.C. Genetic contribution to common epilepsies. Curr. Opin. Neurol. 2011, 24(2):140-145.
72. Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S., Dobrin S.E., Parod J.M., Stephan D.A., Morton D.H. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 2006, 354(13):1370-1377.
73. Striano P., Malacarne M., Cavani S., Pierluigi M., Rinaldi R., Cavaliere M.L., Rinaldi M.M., De Bernardo C., Coppola A., Pintaudi M., Gaggero R., Grammatico P., Striano S., Dallapiccola B., Zara F., Faravelli F. Clinical phenotype and molecular characterization of 6q terminal deletion syndrome: five new cases. Am. J. Med. Genet. A 2006, 140(18):1944-1949.
74. Stromme P., Mangelsdorf M.E., Shaw M.A., Lower K.M., Lewis S.M., Bruyere H., Lutcherath V., Gedeon A.K., Wallace R.H., Scheffer I.E., Turner G., Partington M., Frints S.G., Fryns J.P., Sutherland G.R., Mulley J.C., Gecz J. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat. Genet. 2002, 30(4):441-445.
75. Suls A., Claeys K.G., Goossens D., Harding B., Van Luijk R., Scheers S., Deprez L., Audenaert D., Van Dyck T., Beeckmans S., Smouts I., Ceulemans B., Lagae L., Buyse G., Barisic N., Misson J.P., Wauters J., Del-Favero J., De Jonghe P., Claes L.R. Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients. Hum. Mutat. 2006, 27(9):914-920.
76. Tao J., Van Esch H., Hagedorn-Greiwe M., Hoffmann K., Moser B., Raynaud M., Sperner J., Fryns J.P., Schwinger E., Gecz J., Ropers H.H., Kalscheuer V.M. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am. J. Hum. Genet. 2004, 75(6):1149-1154.
77. Taske N.L., Williamson M.P., Makoff A., Bate L., Curtis D., Kerr M., Kjeldsen M.J., Pang K.A., Sundqvist A., Friis M.L., Chadwick D., Richens A., Covanis A., Santos M., Arzimanoglou A., Panayiotopoulos C.P., Whitehouse W.P., Rees M., Gardiner R.M. Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13-14. Epilepsy Res. 2002, 49(2):157-172.
78. Emery's Elements of Medical Genetics 2004, Elsevier, 436 p. 12th ed. P. Turnpenny, S. Ellard (Eds.).
79. van Bon B.W., Mefford H.C., Menten B., Koolen D.A., Sharp A.J., Nillesen W.M., Innis J.W., de Ravel T.J., Mercer C.L., Fichera M., Stewart H., Connell L.E., Ounap K., Lachlan K., Castle B., Van der Aa N., van Ravenswaaij C., Nobrega M.A., Serra-Juhe C., Simonic I., de Leeuw N., Pfundt R., Bongers E.M., Baker C., Finnemore P., Huang S., Maloney V.K., Crolla J.A., van Kalmthout M., Elia M., Vandeweyer G., Fryns J.P., Janssens S., Foulds N., Reitano S., Smith K., Parkel S., Loeys B., Woods C.G., Oostra A., Speleman F., Pereira A.C., Kurg A., Willatt L., Knight S.J., Vermeesch J.R., Romano C., Barber J.C., Mortier G., Perez-Jurado L.A., Kooy F., Brunner H.G., Eichler E.E., Kleefstra T., de Vries B.B. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J. Med. Genet. 2009, 46(8):511-523.
80. Weaving L.S., Christodoulou J., Williamson S.L., Friend K.L., McKenzie O.L., Archer H., Evans J., Clarke A., Pelka G.J., Tam P.P., Watson C., Lahooti H., Ellaway C.J., Bennetts B., Leonard H., Gecz J. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 2004, 75(6):1079-1093.
81. Westenbroek R.E., Merrick D.K., Catterall W.A. Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons. Neuron 1989, 3(6):695-704.
82. World Health Organization Atlas: Epilepsy Care in the World 2005, WHO Press, Geneva, Switzerland.
83. Yu F.H., Catterall W.A. Overview of the voltage-gated sodium channel family. Genome Biol. 2003, 4(3):207.
84. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T., Catterall W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 2006, 9(9):1142-1149.
85. Zori R.T., Hendrickson J., Woolven S., Whidden E.M., Gray B., Williams C.A. Angelman syndrome: clinical profile. J. Child Neurol. 1992, 7(3):270-280.